Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
Go back to Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones| (NYSE: RCUS) | Delayed: 28.19 -0.23 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.42 | 52 Week High | $ | |||
| Open | $28.67 | 52 Week Low | $ | |||
| Day High | $29.63 | P/E | N/A | |||
| Day Low | $28.00 | EPS | $ | |||
| Volume | 409,225 | |||||

